Zobrazeno 1 - 10
of 436
pro vyhledávání: '"H. Ørskov"'
Publikováno v:
Urological Research. 31:25-31
We evaluated the effect of the somatostatin analogue lanreotide on the development of surgically induced experimental strictures in the anterior urethra of the male rabbit. A total of 74 male rabbits were randomly allocated into four groups. Lanreoti
Impaired fibrinolysis determines the outcome of percutaneus transluminal coronary angioplasty (PTCA)
Autor:
C Sloth, P Nielsen, J Dalsgård, U Abildgård, E Kassis, H Ørskov, Ole Amtorp, K Winther, G G Fornitz, S Husted
Publikováno v:
European Journal of Clinical Investigation. 31:586-592
Background Coronary artery stenosis lesions dilated by percutaneus transluminal coronary angioplasty (PTCA) show a disappointingly frequent recurrence of stenosis. We have investigated the possible role of fibrinolysis and various platelet-release fa
Autor:
H. Ørskov, A. Flyvbjerg
Publikováno v:
Flyvbjerg, A & Ørskov, H C 2005, ' Diabetic angiopathy: New experimental and clinical aspects ', Horm. Metab. Res., vol. 37, pp. S1-S3 .
Autor:
H. Ørskov
Publikováno v:
Metabolism. 45:91-95
Major findings with regard to the somatostatin-growth hormone (GH)-insulin-like growth factor (IGF-1) axis and diabetes are summarized. GH hypersecretion and reduced circulating IGF-1 levels are prevalent in insulin-dependent diabetes. Somatostatin i
Publikováno v:
Clinical Nutrition. 13:105-110
The aim was to investigate the effect of lanreotide (Angiopeptin) on urea synthesis. Lanreotide is a somatostatin analogue used in therapy trials of certain cancers. Cancer patients are often protein catabolic, thus the effect of lanreotide on whole
Publikováno v:
Hormone and Metabolic Research. 25:317-320
Forearm glucose uptake during a hyperglycaemic (10 mmol/l) glucose clamp was diminished to 33% of the normal value (p = 0.012) in six cirrhotic patients compared with matched control subjects. Fasting insulin concentrations were significantly elevate
Autor:
S. E. Christensen, Kaal A, Jens Otto Lunde Jørgensen, E. Lund, H. Ørskov, J. Weeke, A.G. Harris
Publikováno v:
Metabolism. 41:44-50
Twenty-five acromegalic patients were studied during 6 years of treatment with octreotide, with a particular focus on the following parameters: (1) Administration schedule: in 10 patients, continuous subcutaneous (SC) octreotide infusion was compared
Impaired fibrinolysis determines the outcome of percutaneus transluminal coronary angioplasty (PTCA)
Autor:
G G, Fornitz, P, Nielsen, O, Amtorp, E, Kassis, U, Abildgård, C, Sloth, K, Winther, H, Ørskov, J, Dalsgård, S, Husted
Publikováno v:
European journal of clinical investigation. 31(7)
Coronary artery stenosis lesions dilated by percutaneus transluminal coronary angioplasty (PTCA) show a disappointingly frequent recurrence of stenosis. We have investigated the possible role of fibrinolysis and various platelet-release factors - spe
Autor:
H, Ørskov
Publikováno v:
Ugeskrift for laeger. 163(18)
Publikováno v:
Hormone and Metabolic Research. 24:237-239
The acute (TRH-stimulation test), intermediate (0-6 days administration), and long-term (0-30 months administration) effects of SMS 201-995 (octreotide) treatment on thyroid function were studied. Subcutaneous injection of 100 micrograms SMS 201-995